drugset
drugset / Trial / NCT04594733

The Effect of Minocycline and N-acetylcysteine for the Treatment of Fibromyalgia

NCT04594733 ↗

Phase 1/2 Completed 14 enrolled Medical University of South Carolina
RandomizedCrossoverDouble-blindTreatment

Summary

Evaluation of the effect of combinatorial treatment of fibromyalgia patients (standard of care + minocycline + N-acetylcysteine (NAC) relative to standard of care on subjective pain measurement Revised Fibromyalgia Impact Questionnaire (FIQR).

Timeline

Start
2021-12-06
Primary completion
2022-08-31
Completion
2022-08-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Minocycline Small molecule 200 mg —
Comparator N-acetylcysteine Small molecule 1200 mg —

Indications

fibromyalgia